Exosomics S.p.A.
PrivateLast Round
Early Funding
May 16, 2017
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Exosomics S.p.A. is a biotechnology company that develops exosome-based liquid biopsy technologies and diagnostic tests for cancer screening and monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exosomics S.p.A. Comparables
Compare Exosomics S.p.A. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellBio Scientific | 81% | |
| EValuate Diagnostics, Inc. | 80% | |
| Theoria Science, Inc. | 79% | |
Exosomics S.p.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 16, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 869% MoM, from 35 to 339.
Exosomics S.p.A. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exosomics S.p.A.'s valuation, stock price, and market status.